Aging and Cognitive Health Evaluation in Elders (ACHIEVE)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 850
Summary
- Conditions
- Aging
- Cognitive Decline
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 70 years and 84 years
- Gender
- Both males and females
Description
The ACHIEVE study will be a randomized controlled trial nested within the Atherosclerosis Risk in Communities (ARIC) study. 850 70-84 year-old cognitively normal older adults with hearing loss will be randomized 1:1 to the hearing intervention (hearing needs assessment, fitting of hearing devices, e...
The ACHIEVE study will be a randomized controlled trial nested within the Atherosclerosis Risk in Communities (ARIC) study. 850 70-84 year-old cognitively normal older adults with hearing loss will be randomized 1:1 to the hearing intervention (hearing needs assessment, fitting of hearing devices, education/counseling) or successful aging intervention (individual sessions with a health educator covering healthy aging topics). Post baseline, participants will be followed semi-annually for 3 years. Outcomes will include assessments of cognition, social functioning, physical functioning, and quality of life.
Tracking Information
- NCT #
- NCT03243422
- Collaborators
- University of North Carolina
- University of South Florida
- University of Pittsburgh
- University of Mississippi Medical Center
- Wake Forest University
- University of Minnesota
- Investigators
- Principal Investigator: Frank R Lin, MD, PhD Johns Hopkins University Principal Investigator: Josef Coresh Johns Hopkins University
Get Well Soon